New Lawsuit Says Contaminated Zantac Caused Rare Cancer




MIAMI — A Florida man has sued the maker of Zantac in Florida state court, alleging it concealed the fact that its acid reflux drug Zantac (ranitidine) contained “incredibly high levels” of a probable human carcinogen.

In a complaint filed Sept. 13 in the Miami-Dade County Circuit Court, Joseph Galimidi says Sanofi Aventis knew Zantac was “laden” with n-nitrososdimethylamine (NDMA), yet failed to inform the FDA, physicians and the public of that known risk.

NDMA is classified a probable human carcinogen by the Department of Environmental Protection and was formerly used in the production of liquid rocket fuel. According to …

FIRM NAMES
  • Levin Citron Rodal





UPCOMING CONFERENCES




HarrisMartin's Webinar Series: The Hottest Upcoming Device Projects - Strattice Hernia Mesh & Exactech Hip Implants

November 09, 2022

MORE DETAILS



HarrisMartin's MDL Conference: Navigating Current Mass Tort Litigation

November 30, 2022 - New York, NY
The Knickerbocker

MORE DETAILS